{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:28:28Z","timestamp":1791959308292,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1116967"],"award-info":[{"award-number":["OPP1116967"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T23:30:13Z","timestamp":1495063813000},"page":"3506-3514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings"],"prefix":"10.1016","volume":"35","author":[{"given":"Marina","family":"Antill\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Bilcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. David","family":"Paltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia E.","family":"Pitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.05.001_b0005","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.05.001_b0010","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.vaccine.2017.05.001_b0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/adc.75.3.214","article-title":"Impact of age and drug resistance on mortality in typhoid fever","volume":"75","author":"Bhutta","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2017.05.001_b0020","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.05.001_b0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(05)67181-4","article-title":"Typhoid and paratyphoid fever","volume":"366","author":"Bhan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.05.001_b0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3855\/jidc.224","article-title":"Antibiotic resistance among Salmonella enterica serovars Typhi and Paratyphi A in Pakistan (2001\u20132006)","volume":"2","author":"Hasan","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.vaccine.2017.05.001_b0035","first-page":"49","article-title":"Typhoid vaccines: WHO position paper","volume":"83","author":"World Health Organization","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2017.05.001_b0040","first-page":"855","article-title":"Typhoid fever surveillance and vaccine use, South-East Asia and Western Pacific Regions, 2009\u20132013","volume":"63","author":"Date","year":"2014","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.05.001_b0045","doi-asserted-by":"crossref","first-page":"C55","DOI":"10.1016\/j.vaccine.2015.04.028","article-title":"Typhoid fever vaccination strategies","volume":"33","author":"Date","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.001_b0050","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.05.001_b0055","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Lanh","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.05.001_b0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.001_b0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.001_b0070","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.vaccine.2014.02.050","article-title":"Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children","volume":"32","author":"Szu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.001_b0075","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/14760584.2013.845529","article-title":"Development of Vi conjugate - a new generation of typhoid vaccine","volume":"12","author":"Szu","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.05.001_b0080","unstructured":"WHO. SAGE Working Group on Typhoid Vaccines [Internet]; 2016. Available: <http:\/\/www.who.int\/immunization\/policy\/sage\/sage_wg_typhoid_mar2016\/en\/>."},{"key":"10.1016\/j.vaccine.2017.05.001_b0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.trstmh.2005.10.019","article-title":"The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study","volume":"100","author":"Sur","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.05.001_b0090","first-page":"725","article-title":"Treatment cost for typhoid fever at two hospitals in Kolkata, India","volume":"27","author":"Sur","year":"2009","journal-title":"J Heal Popul Nutr"},{"key":"10.1016\/j.vaccine.2017.05.001_b0095","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.05.001_b0100","first-page":"304","article-title":"Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy","volume":"22","author":"Bahl","year":"2004","journal-title":"J Heal Popul Nutr"},{"key":"10.1016\/j.vaccine.2017.05.001_b0105","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4269\/ajtmh.2000.62.644","article-title":"The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam","volume":"62","author":"Lin","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.05.001_b0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-3156.2010.02711.x","article-title":"Cost of illness due to typhoid fever in five Asian countries","volume":"16","author":"Poulos","year":"2011","journal-title":"Trop Med Int Heal"},{"key":"10.1016\/j.vaccine.2017.05.001_b0115","doi-asserted-by":"crossref","first-page":"e29119","DOI":"10.1371\/journal.pone.0029119","article-title":"Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa","volume":"7","author":"Breiman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.001_b0120","first-page":"377","article-title":"Cost of illness due to typhoid fever in Pemba, Zanzibar, East Africa","volume":"32","author":"Riewpaiboon","year":"2014","journal-title":"J Heal Popul Nutr"},{"key":"10.1016\/j.vaccine.2017.05.001_b0130","unstructured":"NICE International. Methods for Economic Evaluation Project: Final Report; 2014."},{"key":"10.1016\/j.vaccine.2017.05.001_b0135","series-title":"Making choices in health: WHO guide to cost-effectiveness analysis","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.vaccine.2017.05.001_b0140","series-title":"Guide for standardization of economic evaluations of immunization programmes","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.vaccine.2017.05.001_b0145","doi-asserted-by":"crossref","first-page":"e2642","DOI":"10.1371\/journal.pntd.0002642","article-title":"Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study","volume":"8","author":"Pitzer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.05.001_b0150","article-title":"Stan: A probabilistic programming language","author":"Carpenter","year":"2016","journal-title":"J Stat Softw"},{"key":"10.1016\/j.vaccine.2017.05.001_b0155","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"Salomon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.05.001_b0160","unstructured":"Comprehensive Multiyear Plan 2013-2017: India [Internet]. [cited 29 Jun 2016]. Available: <http:\/\/www.who.int\/immunization\/programmes_systems\/financing\/countries\/cmyp\/india\/en\/>."},{"key":"10.1016\/j.vaccine.2017.05.001_b0165","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.vaccine.2015.03.084","article-title":"Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania","volume":"33","author":"Mvundura","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.001_b0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2471\/BLT.12.113837","article-title":"Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam","volume":"91","author":"Levin","year":"2013","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.05.001_b0175","series-title":"Decision modelling for health economic evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.vaccine.2017.05.001_b0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1191\/0962280202sm304ra","article-title":"Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods","volume":"11","author":"O\u2019Brien","year":"2002","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.vaccine.2017.05.001_b0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"10.1016\/j.vaccine.2017.05.001_b0190","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1198\/tast.2009.08199","article-title":"Variable importance assessment in regression: linear regression versus random forest","volume":"63","author":"Gr\u00f6mping","year":"2009","journal-title":"Am Stat"},{"key":"10.1016\/j.vaccine.2017.05.001_b0195","first-page":"311","article-title":"A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community","volume":"22","author":"Poulos","year":"2004","journal-title":"J Heal Popul Nutr"},{"key":"10.1016\/j.vaccine.2017.05.001_b0200","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1016\/j.vaccine.2008.09.040","article-title":"The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.001_b0205","unstructured":"UNICEF. Vaccine Price Data. UNICEF Supplies and Logistics. [Internet]. [cited 22 Nov 2016]. Available: <https:\/\/www.unicef.org\/supply\/index_57476.html>."},{"key":"10.1016\/j.vaccine.2017.05.001_b0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost \u2013 effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.05.001_b0215","series-title":"Prevention effectiveness: a guide to decision analysis and economic evaluation","author":"Haddix","year":"2003"},{"key":"10.1016\/j.vaccine.2017.05.001_b0220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4067\/S0716-10182007000600001","article-title":"Fiebre tifoidea: Emergencia, c\u00faspide y declinaci\u00f3n de una enfermedad infecciosa en Chile","volume":"24","author":"Laval","year":"2007","journal-title":"Rev Chil Infectol"},{"key":"10.1016\/j.vaccine.2017.05.001_b0225","first-page":"621","article-title":"Achievements in Public Health, 1900\u20131999: Control of Infectious Diseases","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.05.001_b0230","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.vaccine.2017.05.001_b0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trstmh.2011.10.004","article-title":"The decline of typhoid and the rise of non-typhoid salmonellae and fungal infections in a changing HIV landscape: bloodstream infection trends over 15years in southern Vietnam","volume":"106","author":"Nga","year":"2012","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2017.05.001_b0240","first-page":"CD001261","article-title":"Vaccines for preventing typhoid fever","volume":"1","author":"Anwar","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.001_b9000","doi-asserted-by":"crossref","first-page":"e0005376","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: A meta-regression approach","volume":"11","author":"Antillon","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.001_b9005","doi-asserted-by":"crossref","first-page":"010401","DOI":"10.7189\/jogh.01.010401","article-title":"Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010","volume":"2","author":"Buckle","year":"2012","journal-title":"J Glob Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T02:38:09Z","timestamp":1655692689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":49,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17305868"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}